73357-18-3

Basic information

• Product Name: 4,5-DIMETHOXY-2-NITROPHENYLACETIC ACID
• Synonyms: 2-NITROHOMOVERATRIC ACID;2-(4,5-DIMETHOXY-2-NITROPHENYL)ACETIC ACID;4,5-DIMETHOXY-2-NITROPHENYLACETIC ACID;AKOS AU36-M254;2-(4,5-dimethoxy-2-nitro-phenyl)ethanoic acid;2-(carboxymethyl)-N-hydroxy-4,5-dimethoxybenzeneamine oxide;2-(carboxymethyl)-N-hydroxy-4,5-dimethoxy-benzeneamine oxide;2-[2-(hydroxy-oxido-amino)-4,5-dimethoxy-phenyl]acetic acid
• CAS NO: 73357-18-3
• Molecular Formula: C₁₀H₁₁NO₆
• Molecular Weight: 241.2
• Product Categories: blocks;Carboxes;Aromatic Phenylacetic Acids and Derivatives
• Mol File: 73357-18-3.mol
• Article Data: 11

Chemical Properties

• Melting Point: 206-208°C
• Boiling Point: 433.4°C at 760 mmHg
• Flash Point: 215.9°C
• Appearance: /
• Density: 1.364±0.06 g/cm3(Predicted)
• Vapor Pressure: 2.79E-08mmHg at 25°C
• PKA: 3.98±0.10(Predicted)
• CAS DataBase Reference: 4,5-DIMETHOXY-2-NITROPHENYLACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5-DIMETHOXY-2-NITROPHENYLACETIC ACID(73357-18-3)
• EPA Substance Registry System: 4,5-DIMETHOXY-2-NITROPHENYLACETIC ACID(73357-18-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 73357-18-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H11NO6/c1-16-8-3-6(4-10(12)13)7(11(14)15)5-9(8)17-2/h3,5H,4H2,1-2H3,(H,12,13)/p-1

Upstream product

• 76936-55-5 4-allyl-1,2-dimethoxy-5-nitrobenzene 
• 93-40-3 (3,4-Dimethoxyphenyl)acetic acid 
• 7697-37-2 nitric acid 
• 64-19-7 acetic acid 
• 5663-56-9 2-(3,4-dimethoxyphenyl)acetamide 
• 872273-69-3 (4-benzyloxy-3-methoxy-phenyl)-pyruvic acid 
• 29973-91-9 4-benzyloxy-3-methoxyphenylacetic acid 
• 860189-86-2 (4,5-dimethoxy-2-nitro-phenyl)-pyruvic acid 
• 7722-84-1 dihydrogen peroxide 
• 77-78-1 dimethyl sulfate 
• 85580-22-9 3,4-dimethoxy-2-nitrophenylacetic acid benzhydryl ester 
• 714251-84-0 (4-hydroxy-5-methoxy-2-nitro-phenyl)-acetic acid 
• 50546-76-4 (4,5-dimethoxy-2-nitro-phenyl)-acetic acid amide 

Downstream Products

• 16251-41-5 1-(2'-nitro-4',5'-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline 
• 77513-48-5 1-(4',5'-dimethoxy-2'-nitro-α-oxobenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline 
• 2129-52-4 N-(3,4-dimethoxyphenethyl)-2-(4,5-dimethoxy-2-nitrophenyl)-acetamide 
• 35241-23-7 6,7-dimethoxy-2-methylquinazoline-4(3H)-one 
• 1196872-66-8 tert butyl (4,5-dimethoxy-2-nitrophenyl)acetate 
• 1174219-22-7 rac-α-tert-butoxycarbonyl-4,5-dimethoxy-2-nitrobenzyl bromide 
• 1233875-84-7 4,5-dimethoxy-2-nitrophenylacetic acid allyl ester 
• 59699-64-8 5,6-dimethoxy-3-veratrylidene-indolin-2-one 
• 83511-44-8 1-(2'-amino-4',5'-dimethoxy-α-oxobenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 
• 77538-74-0 1-(4',5'-dimethoxy-2'-nitro-α-oxobenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline methiodide 
• 110934-59-3 N-benzoyl-2-(2-chloroethyl)-5-methoxy-p-benzoquinone imine dimethyl ketal 
• 110905-14-1 N-(tert-butoxycarbonyl)-2-(2-chloroethyl)-5-methoxy-p-benzoquinone imine dimethyl ketal 
• 117559-84-9 N-(methoxycarbonyl)-2-(2-chloroethyl)-5-methoxy-p-benzoquinone imine dimethyl ketal 
• 117559-78-1 N-(methoxycarbonyl)-2-(2-chloroethyl)-4,5-dimethoxyaniline 

Relevant articles and documents

On Demand Attachment and Detachment of rac-2-Br-DMNPA Tailoring to Facilitate Chemical Protein Synthesis

Herein, we developed a bifunctional reagent rac-2-Br-DMNPA 2 for the late-stage protection of peptide cysteine. Through the identification of its t-Bu ester 1 as a more competent form under ligation conditions, facile N-terminal and side-chain caging for

Wavelength-selective photoactivatable protecting groups for thiols

We developed and characterized efficient, remarkably water-soluble photolabile protecting groups for thiols based on 2-nitrobenzyl and (coumarin-4-yl)methyl chromophores, among them two new ones. The protecting groups allow, due to their different absorpt

Indolinone derivatives

Novel derivatives of compound (E)-1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-2H-indol-2-one and the use thereof for the preparation of medicaments for the treatment of tumors in which the tyrosine kinase activity proteins Met, PDGF-R, FGF-R1